B-vitamins are a group of eight water-soluble vitamins (B1/thiamine, B2/riboflavin, B3/niacin, B5/pantothenic acid, B6/pyridoxine, B7/biotin, B9/folate, B12/cobalamin) that function as cofactors in energy metabolism, neurotransmitter synthesis, DNA methylation, and homocysteine metabolism. Deficiency in one or several B-vitamins produces overlapping symptoms including fatigue, cognitive impairment, mood changes, peripheral neuropathy, and megaloblastic anemia, making biomarker testing essential for targeted intervention.
Active forms of several B-vitamins bypass common genetic polymorphisms. Methylfolate (L-5-MTHF) bypasses MTHFR polymorphisms that reduce conversion from synthetic folic acid; approximately 30-50% of populations carry at least one variant. Methylcobalamin is directly usable by the central nervous system without the methylation step required for cyanocobalamin. Pyridoxal-5-phosphate (P-5-P) is the active form of B6 and bypasses liver conversion. These active forms are particularly relevant for individuals with cognitive, mood, or neurological presentations that respond inadequately to standard forms.
Deficiency testing is straightforward and worthwhile in symptomatic individuals. Target serum B12 above 400 pg/mL, or methylmalonic acid (more sensitive) below 270 nmol/L. Homocysteine elevation suggests inadequate B6, B9, or B12 status. Populations at elevated risk include vegans and vegetarians (B12), metformin users (B12 malabsorption), elderly adults (atrophic gastritis reducing intrinsic factor), post-bariatric surgery patients, and pregnant women (folate). High-dose B6 supplementation above 100mg daily for extended periods carries peripheral neuropathy risk and should be avoided except under medical supervision.